The global market for thyroid support supplements was valued at approximately USD 2.00 billion in 2025 and is anticipated to grow to USD 4.08 billion by 2033, reflecting a compound annual growth rate (CAGR) of about 9.29% between 2025 and 2033. Consumer interest is increasingly focused on natural and herbal supplements containing ingredients like iodine, selenium, zinc, ashwagandha, and vitamin B12 to support thyroid function and metabolic balance.

The global corporate wellness market was valued at approximately USD 55.10 billion in 2025 and is expected to grow to USD 63.90 billion by 2030, expanding at a compound annual growth rate (CAGR) of around 3.01% during 2025 to 2030. Increasing awareness surrounding employee health and well-being is a pivotal factor fueling this market’s development.

The global coronary artery bypass graft (CABG) market was valued at approximately USD 20.43 billion in 2025 and is expected to reach USD 27.66 billion by 2033, with a compound annual growth rate (CAGR) of about 3.86% from 2025 to 2033. The increasing prevalence of cardiovascular diseases worldwide is a primary factor stimulating market expansion.

The global surgical sutures market was valued at approximately USD 5.02 billion in 2025 and projected to reach USD 6.46 billion by 2030, reflecting a compound annual growth rate (CAGR) of 5.2% during the forecast period. Market growth is fueled by increasing surgical procedures globally and innovations in suture materials, including smart and antibacterial sutures.

The global extractable and leachable (E&L) testing services market was valued at approximately USD 1.23 billion in 2025 and is projected to reach USD 3.57 billion by 2033, growing at an impressive compound annual growth rate (CAGR) of 14.3% from 2025 to 2033. The rapid expansion of the pharmaceutical and biotechnology industries worldwide significantly propels the demand for these critical testing services.

The global skin cancer diagnostics market was valued at approximately USD 10.07 billion in 2025 and is predicted to grow to USD 15.67 billion by 2033, exhibiting a compound annual growth rate (CAGR) of 5.7% during 2025 to 2033. Growth is driven by advancements in technology, increasing integration of artificial intelligence (AI) in diagnostics, and a rising patient preference for non-invasive diagnostic methods.

The global organic rheology modifiers market was valued at approximately USD 4.44 billion in 2024 and is projected to grow at a CAGR of around 3.8% through 2030, reaching about USD 5.56 billion.

The global cellulose acetate market was valued at approximately USD 6.2 billion in 2024 and is expected to reach around USD 8.4 billion by 2032, growing at a CAGR of 4.6% from 2025 to 2032. This growth is primarily driven by increasing demand in textiles and apparel, along with expanding applications in eyewear frames and photographic films. The lightweight, durable, and flexible properties of cellulose acetate make it highly favored in these sectors.

The global fermenters market size was valued at USD 1.98 billion in 2025 and is anticipated to grow to USD 2.97 billion by 2030, exhibiting a CAGR of 8.4% between 2025 and 2030. This growth is largely driven by escalating incidence of chronic illnesses such as cancer, diabetes, and cardiovascular diseases, which have increased the demand for innovative biological therapies.

The global tetrahydrofuran (THF) market size was valued at USD 4.73 billion in 2025 and is forecasted to grow at a compound annual growth rate (CAGR) of 6.6% from 2025 to 2032, reaching approximately USD 8.9 billion.